Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography

BACKGROUND: Dual antiplatelet therapy with clopidogrel and aspirin is the standard of care for patients undergoing percutaneous coronary intervention (PCI). OBJECTIVE: To determine the clinical characteristics associated with high on-treatment platelet reactivity (HPR) of patients undergoing PCI aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xu-Min, Han, Wen-Zheng, Qiu, Xing-Biao, Fang, Wei-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832659/
https://www.ncbi.nlm.nih.gov/pubmed/27326080
http://dx.doi.org/10.1136/heartasia-2013-010296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832659/
https://www.ncbi.nlm.nih.gov/pubmed/27326080
http://dx.doi.org/10.1136/heartasia-2013-010296

Ejemplares similares